Cite

HARVARD Citation

    Cazorla-Morallon, D. et al. (n.d.). Stroke and myocardial infarction prevention with GLP1 analogues in high or very-high cardiovascular risk diabetic patients. European heart journal. p. . [Online]. 
  
Back to record